GH Research (GHRS) Total Liabilities (2020 - 2025)
GH Research (GHRS) recorded quarterly Total Liabilities of $8.5 million in Q4 2025, down 19.75% quarter-over-quarter from $10.6 million in Q3 2025, and down 8.53% on a YoY basis from $9.3 million in Q4 2024.
GH Research (GHRS) Total Liabilities (2020 - 2025) Analysis & Trends
GH Research's Total Liabilities history runs 6 years deep, the most recent figure standing at $8.5 million for Q4 2025.
- In Q4 2025, Total Liabilities fell 8.53% year-over-year to $8.5 million; the TTM figure through Dec 2025 stood at $8.5 million (down 8.53% YoY), while the FY2025 annual figure was $8.5 million, down 8.53% from the prior year.
- Total Liabilities was $8.5 million for Q4 2025 at GH Research, down from $10.6 million in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $10.6 million in Q3 2025 to a low of $2.0 million in Q3 2021.
- Historically, Total Liabilities has averaged $6.9 million across 5 years, with a median of $7.4 million in 2023.
- The sharpest annual moves came in 2021 and 2025: Total Liabilities surged 159.69% in 2021, then fell 8.53% in 2025.
- A 5-year view of Total Liabilities shows it stood at $3.4 million in 2021, then jumped by 34.42% to $4.5 million in 2022, then jumped by 61.28% to $7.3 million in 2023, then climbed by 27.14% to $9.3 million in 2024, then decreased by 8.53% to $8.5 million in 2025.
- The last three Total Liabilities figures came in at $8.5 million (Q4 2025), $10.6 million (Q3 2025), and $10.2 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | 1.74 Mn |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | 15.48 Mn |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 16.35 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 731.60 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | 19.51 Mn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | 10.44 Mn |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | 943,068.00 |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 7.12 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | 137.56 Mn |
| 10 | GH Research | 9.73 Bn | 9.63 Bn | - | 8.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 8.53 Mn |
| Sep 30, 2025 | 10.63 Mn |
| Jun 30, 2025 | 10.25 Mn |
| Mar 31, 2025 | 10.24 Mn |
| Dec 31, 2024 | 9.32 Mn |
| Sep 30, 2024 | 10.25 Mn |
| Jun 30, 2024 | 8.30 Mn |
| Mar 31, 2024 | 7.84 Mn |
| Dec 31, 2023 | 7.33 Mn |
| Sep 30, 2023 | 6.80 Mn |
| Jun 30, 2023 | 7.29 Mn |
| Mar 31, 2023 | 7.43 Mn |
| Dec 31, 2022 | 4.55 Mn |
| Sep 30, 2022 | 3.39 Mn |
| Jun 30, 2022 | 3.10 Mn |
| Mar 31, 2022 | 4.07 Mn |
| Dec 31, 2021 | 3.38 Mn |
| Sep 30, 2021 | 2.03 Mn |
| Dec 31, 2020 | -5.67 Mn |